
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16564252
[patent_doc_number] => 10889610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Alpha-D-galactoside inhibitors of galectins
[patent_app_type] => utility
[patent_app_number] => 16/313628
[patent_app_country] => US
[patent_app_date] => 2017-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21304
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313628 | Alpha-D-galactoside inhibitors of galectins | Jul 8, 2017 | Issued |
Array
(
[id] => 17648483
[patent_doc_number] => 11351184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Preparation of
[patent_app_type] => utility
[patent_app_number] => 16/629002
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8121
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629002 | Preparation of | Jul 6, 2017 | Issued |
Array
(
[id] => 12001798
[patent_doc_number] => 20170305954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'SYNTHESIS OF 2\', 3\'-DIDEOXYNUCLEOSIDES FOR AUTOMATED DNA SYNTHESIS AND PYROPHOSPHOROLYSIS ACTIVATED POLYMERIZATION'
[patent_app_type] => utility
[patent_app_number] => 15/643053
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11489
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643053 | SYNTHESIS OF 2', 3'-DIDEOXYNUCLEOSIDES FOR AUTOMATED DNA SYNTHESIS AND PYROPHOSPHOROLYSIS ACTIVATED POLYMERIZATION | Jul 5, 2017 | Abandoned |
Array
(
[id] => 16290134
[patent_doc_number] => 10766970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Modified carbohydrates, compositions comprising the same, and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/311992
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311992 | Modified carbohydrates, compositions comprising the same, and methods of making and using the same | Jun 29, 2017 | Issued |
Array
(
[id] => 14653363
[patent_doc_number] => 20190233810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Method for Isolating Nucleic Acids with Bivalent Cations and Elution with a Cation Chelating Agent
[patent_app_type] => utility
[patent_app_number] => 16/312212
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312212 | Method for Isolating Nucleic Acids with Bivalent Cations and Elution with a Cation Chelating Agent | Jun 29, 2017 | Abandoned |
Array
(
[id] => 14974157
[patent_doc_number] => 10440951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Mixtures of sabadilla alkaloids and spinosyns and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/637358
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2202
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15637358
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/637358 | Mixtures of sabadilla alkaloids and spinosyns and uses thereof | Jun 28, 2017 | Issued |
Array
(
[id] => 14031855
[patent_doc_number] => 10227668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Method for preparing fructose or xylulose from biomass containing glucose or xylose using butanol, and method for separating the same
[patent_app_type] => utility
[patent_app_number] => 15/635060
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6681
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635060
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635060 | Method for preparing fructose or xylulose from biomass containing glucose or xylose using butanol, and method for separating the same | Jun 26, 2017 | Issued |
Array
(
[id] => 14852155
[patent_doc_number] => 10414789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
[patent_app_type] => utility
[patent_app_number] => 15/630741
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 27597
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15630741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/630741 | Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use | Jun 21, 2017 | Issued |
Array
(
[id] => 11992413
[patent_doc_number] => 20170296568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/628684
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6733
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628684
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/628684 | SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME | Jun 20, 2017 | Abandoned |
Array
(
[id] => 17875514
[patent_doc_number] => 11447515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Triterpene saponins, methods of synthesis and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/626046
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 38706
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626046 | Triterpene saponins, methods of synthesis and uses thereof | Jun 15, 2017 | Issued |
Array
(
[id] => 14291729
[patent_doc_number] => 10285969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Mangiferin-6-O-berberine salt and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/619936
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7095
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619936 | Mangiferin-6-O-berberine salt and preparation method and use thereof | Jun 11, 2017 | Issued |
Array
(
[id] => 12976066
[patent_doc_number] => 20170340774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => POLETHYLENE GLYCOL HYDROGEL INJECTION
[patent_app_type] => utility
[patent_app_number] => 15/619947
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619947
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619947 | POLETHYLENE GLYCOL HYDROGEL INJECTION | Jun 11, 2017 | Abandoned |
Array
(
[id] => 14778239
[patent_doc_number] => 20190264017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => SOLID SUPPORT
[patent_app_type] => utility
[patent_app_number] => 16/305372
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305372 | Solid support | Jun 6, 2017 | Issued |
Array
(
[id] => 12185393
[patent_doc_number] => 20180044330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/615466
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10878
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615466 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | Jun 5, 2017 | Issued |
Array
(
[id] => 16984596
[patent_doc_number] => 11071746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation
[patent_app_type] => utility
[patent_app_number] => 16/308384
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4751
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308384 | Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation | Jun 4, 2017 | Issued |
Array
(
[id] => 15381821
[patent_doc_number] => 10532069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Compositions and methods for treating joints
[patent_app_type] => utility
[patent_app_number] => 15/612267
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 14177
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612267
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612267 | Compositions and methods for treating joints | Jun 1, 2017 | Issued |
Array
(
[id] => 15254089
[patent_doc_number] => 20190375778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/305159
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305159 | ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | May 30, 2017 | Abandoned |
Array
(
[id] => 12224699
[patent_doc_number] => 20180063059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => '2\'-FLUORO-6\'-METHYLENE CARBOCYCLIC NUCLEOSIDES AND METHODS OF TREATING VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/609080
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24411
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609080 | 2'-Fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections | May 30, 2017 | Issued |
Array
(
[id] => 12580821
[patent_doc_number] => 20180085436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => METHODS FOR INTRODUCING MANNOSE 6-PHOSPHATE AND OTHER OLIGOSACCHARIDES ONTO GLYCOPROTEINS AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/602020
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602020 | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof | May 21, 2017 | Issued |
Array
(
[id] => 14306255
[patent_doc_number] => 20190142831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => TREATMENT OF ROSACEA WITH P38 AND ERK KINASE PATHWAY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/098995
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098995
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098995 | Treatment of rosacea with P38 and Erk kinase pathway inhibitors | May 4, 2017 | Issued |